Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting.
Barda N, Dagan N, Ben-Shlomo Y, Kepten E, Waxman J, Ohana R, Hernán MA, Lipsitch M, Kohane I, Netzer D, Reis BY, Balicer RD.. Avendaño-Solá C, et al.J Clin Invest. 2021 Sep 2:152740. doi: 10.1172/JCI152740. Online ahead of print.J Clin Invest. 2021.PMID: 34473652.
![top](data:image/svg+xml,%3Csvg%20xmlns="http://www.w3.org/2000/svg"%20width="16"%20height="16"%3E%3Crect%20fill-opacity="0"/%3E%3C/svg%3E "top")
